Global Head Lice Infestation Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Head Lice Infestation Drug Market
The global Head Lice Infestation Drug market size is projected to reach US$ 478.5 million by 2027, from US$ 381.2 million in 2020, at a CAGR of 3.3% during 2021-2027.
Global Head Lice Infestation Drug Scope and Segment
The global Head Lice Infestation Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Head Lice Infestation Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Lotion
Creams
Shampoo
Other
By the end users/application, this report covers the following segments
Children
Adult
Competitive Landscape:
The report provides a list of all the key players in the Head Lice Infestation Drug market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Head Lice Infestation Drug key manufacturers in this market include:
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO

TABLE OF CONTENT

1 Head Lice Infestation Drug Market Overview
1.1 Head Lice Infestation Drug Product Overview
1.2 Head Lice Infestation Drug Market Segment by Type
1.2.1 Lotion
1.2.2 Creams
1.2.3 Shampoo
1.2.4 Other
1.3 Global Head Lice Infestation Drug Market Size by Type
1.3.1 Global Head Lice Infestation Drug Market Size Overview by Type (2016-2027)
1.3.2 Global Head Lice Infestation Drug Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Head Lice Infestation Drug Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Head Lice Infestation Drug Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Head Lice Infestation Drug Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Head Lice Infestation Drug Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Head Lice Infestation Drug Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Head Lice Infestation Drug Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Head Lice Infestation Drug Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Head Lice Infestation Drug Sales Breakdown by Type (2016-2030)
1.4.2 Europe Head Lice Infestation Drug Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Head Lice Infestation Drug Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Type (2016-2030)

2 Global Head Lice Infestation Drug Market Competition by Company
2.1 Global Top Players by Head Lice Infestation Drug Sales (2016-2030)
2.2 Global Top Players by Head Lice Infestation Drug Revenue (2016-2030)
2.3 Global Top Players Head Lice Infestation Drug Price (2016-2030)
2.4 Global Top Manufacturers Head Lice Infestation Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Head Lice Infestation Drug Market Competitive Situation and Trends
2.5.1 Head Lice Infestation Drug Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Head Lice Infestation Drug Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Head Lice Infestation Drug as of 2020)
2.7 Date of Key Manufacturers Enter into Head Lice Infestation Drug Market
2.8 Key Manufacturers Head Lice Infestation Drug Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Head Lice Infestation Drug Status and Outlook by Region
3.1 Global Head Lice Infestation Drug Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Head Lice Infestation Drug Historic Market Size by Region
3.2.1 Global Head Lice Infestation Drug Sales in Volume by Region (2016-2030)
3.2.2 Global Head Lice Infestation Drug Sales in Value by Region (2016-2030)
3.2.3 Global Head Lice Infestation Drug Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Head Lice Infestation Drug Forecasted Market Size by Region
3.3.1 Global Head Lice Infestation Drug Sales in Volume by Region (2022-2027)
3.3.2 Global Head Lice Infestation Drug Sales in Value by Region (2022-2027)
3.3.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Head Lice Infestation Drug by Application
4.1 Head Lice Infestation Drug Market Segment by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Head Lice Infestation Drug Market Size by Application
4.2.1 Global Head Lice Infestation Drug Market Size Overview by Application (2016-2027)
4.2.2 Global Head Lice Infestation Drug Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Head Lice Infestation Drug Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Head Lice Infestation Drug Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Head Lice Infestation Drug Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Head Lice Infestation Drug Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Head Lice Infestation Drug Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Head Lice Infestation Drug Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Head Lice Infestation Drug Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Head Lice Infestation Drug Sales Breakdown by Application (2016-2030)
4.3.2 Europe Head Lice Infestation Drug Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Head Lice Infestation Drug Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Application (2016-2030)

5 North America Head Lice Infestation Drug by Country
5.1 North America Head Lice Infestation Drug Historic Market Size by Country
5.1.1 North America Head Lice Infestation Drug Sales in Volume by Country (2016-2030)
5.1.2 North America Head Lice Infestation Drug Sales in Value by Country (2016-2030)
5.2 North America Head Lice Infestation Drug Forecasted Market Size by Country
5.2.1 North America Head Lice Infestation Drug Sales in Volume by Country (2022-2027)
5.2.2 North America Head Lice Infestation Drug Sales in Value by Country (2022-2027)

6 Europe Head Lice Infestation Drug by Country
6.1 Europe Head Lice Infestation Drug Historic Market Size by Country
6.1.1 Europe Head Lice Infestation Drug Sales in Volume by Country (2016-2030)
6.1.2 Europe Head Lice Infestation Drug Sales in Value by Country (2016-2030)
6.2 Europe Head Lice Infestation Drug Forecasted Market Size by Country
6.2.1 Europe Head Lice Infestation Drug Sales in Volume by Country (2022-2027)
6.2.2 Europe Head Lice Infestation Drug Sales in Value by Country (2022-2027)

7 Asia-Pacific Head Lice Infestation Drug by Region
7.1 Asia-Pacific Head Lice Infestation Drug Historic Market Size by Region
7.1.1 Asia-Pacific Head Lice Infestation Drug Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Head Lice Infestation Drug Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Head Lice Infestation Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Head Lice Infestation Drug Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Head Lice Infestation Drug Sales in Value by Region (2022-2027)

8 Latin America Head Lice Infestation Drug by Country
8.1 Latin America Head Lice Infestation Drug Historic Market Size by Country
8.1.1 Latin America Head Lice Infestation Drug Sales in Volume by Country (2016-2030)
8.1.2 Latin America Head Lice Infestation Drug Sales in Value by Country (2016-2030)
8.2 Latin America Head Lice Infestation Drug Forecasted Market Size by Country
8.2.1 Latin America Head Lice Infestation Drug Sales in Volume by Country (2022-2027)
8.2.2 Latin America Head Lice Infestation Drug Sales in Value by Country (2022-2027)

9 Middle East and Africa Head Lice Infestation Drug by Country
9.1 Middle East and Africa Head Lice Infestation Drug Historic Market Size by Country
9.1.1 Middle East and Africa Head Lice Infestation Drug Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Head Lice Infestation Drug Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Head Lice Infestation Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Head Lice Infestation Drug Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Head Lice Infestation Drug Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Head Lice Infestation Drug Business
10.1 Bayer
10.1.1 Bayer Corporation Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Bayer Head Lice Infestation Drug Products Offered
10.1.5 Bayer Recent Development
10.2 Omega Pharma
10.2.1 Omega Pharma Corporation Information
10.2.2 Omega Pharma Introduction and Business Overview
10.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Omega Pharma Head Lice Infestation Drug Products Offered
10.2.5 Omega Pharma Recent Development
10.3 Thornton and Ross
10.3.1 Thornton and Ross Corporation Information
10.3.2 Thornton and Ross Introduction and Business Overview
10.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Thornton and Ross Head Lice Infestation Drug Products Offered
10.3.5 Thornton and Ross Recent Development
10.4 Prestige Brands
10.4.1 Prestige Brands Corporation Information
10.4.2 Prestige Brands Introduction and Business Overview
10.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Prestige Brands Head Lice Infestation Drug Products Offered
10.4.5 Prestige Brands Recent Development
10.5 Perrigo
10.5.1 Perrigo Corporation Information
10.5.2 Perrigo Introduction and Business Overview
10.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Perrigo Head Lice Infestation Drug Products Offered
10.5.5 Perrigo Recent Development
10.6 Actavis
10.6.1 Actavis Corporation Information
10.6.2 Actavis Introduction and Business Overview
10.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Actavis Head Lice Infestation Drug Products Offered
10.6.5 Actavis Recent Development
10.7 Reckitt Benckier
10.7.1 Reckitt Benckier Corporation Information
10.7.2 Reckitt Benckier Introduction and Business Overview
10.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Reckitt Benckier Head Lice Infestation Drug Products Offered
10.7.5 Reckitt Benckier Recent Development
10.8 Tyratech
10.8.1 Tyratech Corporation Information
10.8.2 Tyratech Introduction and Business Overview
10.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Tyratech Head Lice Infestation Drug Products Offered
10.8.5 Tyratech Recent Development
10.9 Shionogi
10.9.1 Shionogi Corporation Information
10.9.2 Shionogi Introduction and Business Overview
10.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Shionogi Head Lice Infestation Drug Products Offered
10.9.5 Shionogi Recent Development
10.10 TecLabs
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Head Lice Infestation Drug Product Category, Application and Specification
10.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 TecLabs Recent Development
10.11 Arborpharma
10.11.1 Arborpharma Corporation Information
10.11.2 Arborpharma Introduction and Business Overview
10.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Arborpharma Head Lice Infestation Drug Products Offered
10.11.5 Arborpharma Recent Development
10.12 Major Pharmaceuticals
10.12.1 Major Pharmaceuticals Corporation Information
10.12.2 Major Pharmaceuticals Introduction and Business Overview
10.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Major Pharmaceuticals Head Lice Infestation Drug Products Offered
10.12.5 Major Pharmaceuticals Recent Development
10.13 Logic Products
10.13.1 Logic Products Corporation Information
10.13.2 Logic Products Introduction and Business Overview
10.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.13.4 Logic Products Head Lice Infestation Drug Products Offered
10.13.5 Logic Products Recent Development
10.14 Tianren
10.14.1 Tianren Corporation Information
10.14.2 Tianren Introduction and Business Overview
10.14.3 Tianren Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.14.4 Tianren Head Lice Infestation Drug Products Offered
10.14.5 Tianren Recent Development
10.15 ParaPRO
10.15.1 ParaPRO Corporation Information
10.15.2 ParaPRO Introduction and Business Overview
10.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue and Gross Margin (2016-2030)
10.15.4 ParaPRO Head Lice Infestation Drug Products Offered
10.15.5 ParaPRO Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Head Lice Infestation Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Head Lice Infestation Drug Industrial Chain Analysis
11.4 Head Lice Infestation Drug Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Head Lice Infestation Drug Distributors
12.3 Head Lice Infestation Drug Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample